R&D Group Vitak

  • Website: http://www.vitak.com/home/
  • Size: 11-50 employees
  • Overview: 1) R & D Department: * Cardiovascular disease * Calcium and bone metabolism * Nephrology * Cartilage disorders * Dermatology * In vitro cell cultures * Biomarker development * Research environment 2) Diagnostics Department: Besides all routine biomarkers in the areas of cardiovascular disease, calcium and bone metabolism (osteoporosis, osteopenia), diseases of the cartilage (osteoarthritis, rheumatoid arthritis), chronic kidney disease (including hemodialysis) and inflammation, our target is to bring at least one unique specialty marker per year in one of these fields. Presently available is dp-ucMGP, a circulating risk marker for cardiovascular disease that can only be measured at VitaK. Within shortly we hope to launch new markers for myocardial infarction, osteoarthritis and calcifying tumours. 3) Human Trial Center: We have a substantial investment program to increase its own clinical equipment for in-house clinical endpoint measurements in human intervention trials and clinical trials for the food and pharmaceutical industry 4) PhD Education; Our Group has developed a unique PhD education and training program in which we collaborate with a number of European universities. A novel concept is the combination of scientific and commercial training in which writing of patent applications goes together with writing high impact scientific papers. 5) Consultancy

Search 1.5 billion
Email & Phone#

Browse to anyone's Linkedin profile, and Contactout will find that person's email address and phone number

Start your free trial
(300+ Reviews)

People also viewed these companies

  • E-Commerce
  • E-Commerce
  • E-Commerce
  • Health Care
  • Music
  • Enterprise Software